Anders Schultz, MD, FRCPC Edmonton, AB, Canada Send page to friend via: Share via: You may also be interested in
Starting Dose: 0.25 mg once daily Optimal Dose: 0.25 to 0.5 mg daily, with option to split into two doses Administration: Subcutaneous injection, abdomen preferred for systemic effects Timing: Morning injection, at least 2 hours away from Retatrutide Duration: 4 to 8 weeks cycles with 2 to 4 weeks off between What the Research Community Reports User experiences with BPC-157 alongside Retatrutide consistently highlight reduced GI symptoms
Our team provides continuous support, helping you navigate your plan with clarity and confidence
Your InCare provider will track inflammation levels, tissue health, and strength recovery over time to ensure real results
Its being researched for its potential to support healing in tendons, ligaments, and the digestive tract